ClinicalTrials.gg
CompletedNCT07478406Updated Nov 10, 2026

Relatıonshıp Between Pelvıc Floor and Venous Insuffıcıency

An interventional study of Pelvic exercise group and control group in Chronic Venous Insufficiency, Pelvic Floor, Exercise, sponsored by Istanbul Arel University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Primary conditionVenous InsufficiencyRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Venous Insufficiency
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Venous Insufficiency.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Istanbul Arel University · Not applicable, Interventional, and Treatment

Updated Nov 10, 2026Now CompletedStart date moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
30 Years to 65 Years
Sex
All
01

Study summary

  • The aim of the study is to examine the effects of pelvic floor exercises combined with a regular exercise program and compression stockings on symptomatic improvement, capillary circulation, edema, and functional capacity in individuals with chronic venous insufficiency. It is to compare whether these two methods are superior to each other in terms of clinical and functional outcomes. To evaluate the reliability of this combination application, patient compliance, and its contribution to quality of life. In addition to the researcher (doctoral student), a consultant and a research physician will be involved in this study to conduct clinical applications, observe the process, and collect data. The study will be conducted at a single center.
Read the detailed description

The aim of this study is to investigate the effects of a regular exercise program combined with compression stocking use versus pelvic floor exercise application on symptomatic improvement, capillary circulation, edema, and functional capacity in individuals with chronic venous insufficiency. It aims to compare whether these two methods are superior to each other in terms of clinical and functional outcomes. It also aims to evaluate the reliability of this combination application, patient compliance, and its contribution to quality of life and hemodynamics.

02

Conditions studied

  • Chronic Venous Insufficiency, Pelvic Floor, Exercise

Browse trials for

Keywords

  • Venous Insufficiency
  • Exercise
  • Compression Bandages
03

In context

Venous Insufficiency Reclassified

162 studies on the registry are indexed under Venous Insufficiency; 14 are open to participants now.

This study's enrollment of 32 is below the median of 60 across 127 interventional studies indexed under Venous Insufficiency.

Browse Venous Insufficiency studies →

Lead sponsor

Istanbul Arel University is the lead sponsor of 44 studies on the registry; 14 are open to participants now.

Compared within Venous Insufficiency, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Those diagnosed with primary lower extremity venous insufficiency based on Doppler ultrasound measurements
  • Having clinical symptoms and findings
  • Not using any medication for varicose vein treatment
  • Not having undergone varicose vein surgery previously
  • Volunteering to participate in the study
  • Not receiving physical therapy or rehabilitation services for any reason during the study,
  • Possessing the necessary technical equipment and knowledge for telerehabilitation
  • No history of vainismus or chronic pelvic pain

Exclusion criteria

Exclusion Criteria:

  • DVT
  • Heart failure
  • Thrombophlebitis
  • Venous ulcer
  • Skin pigmentation
  • Lipodermatosclerosis
  • Bleeding varicose vein
  • Open wounds and acute infections
  • Uncontrolled hypertension
  • Orthopedic and neurological diseases that may prevent physical activity
  • Non-cooperative patients with communication problems
  • Failure to comply with the treatment program
  • Pregnancy
  • Having a for exercise
  • Having communication problems (auditory, visual, etc.)
  • Having difficulty accessing the internet
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Home exercise group

    Participants in this group will be given a home exercise program. Participants are asked to do 5 minutes of warm-up exercises beforehand. Participants will perform 10 repetitions of wall-supported toe raises targeting the quadriceps muscle while standing, and 10 repetitions of leg lifts with one leg bent and the other leg straight while lying on their back. Participants will perform 10 wall-supported squats while standing. Ten repetitions of hip extension will be performed while standing with support from the wall, facing the wall. These exercises will be performed separately for each leg. Taking into account the individuals' right to healthcare, if requested, the exercise program will continue for 6 weeks after the 6-week study period is completed.

    Diagnostic Test: control group

  • Active comparator
    Group/ pelvic floor exercises

    Participants in this group will undergo a 20-minute exercise program twice a week via online platforms (Zoom, WhatsApp). The exercise program will consist of pelvic floor exercises. Participants are asked to do 5 minutes of warm-up exercises beforehand. Participants will exhale to their expiratory reserve volume, hold their breath (apnea) 10 times. They will perform 10 repetitions of hip lifts in bed. They will perform 10 repetitions of knee-supported adduction and abduction exercises in a lying position. Pelvic floor exercises will be performed for approximately 6-8 seconds. These exercises will be performed separately for each leg. Cool-down exercises will be performed under patient control. The exercise program will continue for 6 weeks. Participants will continue to wear compression stockings throughout the 6-week period. Participants will continue to perform the exercises on other days according to the home exercise protocol provided to them.

    Diagnostic Test: Pelvic exercise group

Interventions

  • Diagnostic testPelvic exercise group

    The original aspect of the study is that it contributes to the creation of a multidisciplinary treatment protocol by examining the synergistic effects of these two approaches on pelvic floor exercises. It is anticipated that the findings will contribute to the creation of individualized and effective intervention strategies that can serve as a guide for clinicians.

    Also known as: Exercise, Doppler ultrasound

  • Diagnostic testcontrol group

    This group will be randomly assigned to receive a home exercise program and an exercise and compression stocking diary application.

    Also known as: exercises

06

What researchers measure

Primary outcomes

  1. The effect of pelvic exercises on lower extremity circulation in patients evaluated with Doppler ultrasound

    Our study has a randomised, controlled, prospective study design. Participants will be randomly assigned to either the pelvic floor exercise group or the control group using the random.org website and randomisation method. Individuals who sign a voluntary consent form will be evaluated to compare the effects of pelvic floor exercises on the pelvic floor, looking at their superiority over exercise and compression stockings in individuals with chronic venous insufficiency. Individuals will be evaluated face-to-face at a private hospital approved by the ethics committee. The study will report participants' Doppler data, pelvic floor status, and exercise processes. Data will be collected again after a 6-week follow-up period and reported with statistical analysis. The effect of pelvic exercises will be reported here.

    Time frame: 6 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Jun 2026, 2 months.

Of 37 non-industry interventional studies with no phase under Venous Insufficiency, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 60. This study's 2 months is below that.

Counting every sponsor, half of 46 studies reached it within 15 months; a quarter within 9 and three quarters within 38.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Mar 2026 → Apr 2026, primary completion Mar 2026 → Jun 2026 and completion Apr 2026 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Mar 17, 2026
StartActual
Apr 5, 2026was Mar 2026
Primary completionActual
Jun 28, 2026was Mar 2026
CompletionActual
Aug 1, 2026was Apr 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Nov 10, 2026
Start date
Mar 5, 2026→Apr 5, 2026 (actual)
Nov 10, 2026
Primary completion
Mar 28, 2026→Jun 28, 2026 (actual)
Nov 10, 2026
Study completion
Apr 1, 2026→Aug 1, 2026 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Enrolling by invitation→Completed
    Start date Mar 5, 2026→Apr 5, 2026 (now actual)
    Primary completion Mar 28, 2026→Jun 28, 2026 (now actual)
    Study completion Apr 1, 2026→Aug 1, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07478406
Lead sponsor
Istanbul Arel University
Responsible party
Sponsor
First posted
Mar 17, 2026
Start date
Apr 5, 2026
Primary completion
Jun 28, 2026
Completion
Aug 1, 2026
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion